SINGAPORE, March 27, 2025 /PRNewswire/ — Singapore-based B2B healthcare AI platform FlocCare Pte. Ltd. has just raised US$500K, with backing from DTVP, SDTA Ventures and prominent healthcare angel investors in Singapore.

This funding will fuel FlocCare’s expansion to more disease specific gen AI models to empower clinics and hospitals for preventative health for their patients:

Adding cardio-vascular, CKD, Women’s Health and Oncology to their AI models Expanding to the UAE Expanding the AI and product teams

With Asia’s chronic disease burden and ageing population, FlocCare is empowering the overburdened healthcare ecosystem with preventative health information with their AI models that are 50X faster, fact checked scalable and regulatory-compliant, making preventative healthcare accessible and actionable.

Co-founded by serial entrepreneur Shilpa Karkeraa (CEO) and Rhythm Jolly (CBO), FlocCare has a vision to take healthcare awareness a billion lives. The purpose of the company stems from the founders’ personal journeys as caregivers.

#HealthcareInnovation #floccare #AIinHealthcare

FlocCare founders Shilpa Karkeraa and Rhythm JollyFlocCare founders Shilpa Karkeraa and Rhythm Jolly

 

Source link

This content was prepared by our news partner, Cision PR Newswire. The opinions and the content published on this page are the author’s own and do not necessarily reflect the views of Siam News Network
You May Also Like

Shanton Reveals Topline Data from Phase 2b Study in Refractory Gout Patients

SAP-001 is Shanton’s lead investigational compound with First- and Best-in-Class potential in…

SK bioscience, IDT Biologika and Vaxxas Selected for Next-Generation Influenza Vaccine development Financed by the European Union

SK–IDT–Vaxxas consortium establishes strategic entry point for high-density microarray patch (HD-MAP) vaccines…

Dreame Debuts AURORA Smartphones at AWE 2026 With Modular Camera System and Luxury Lineup

Dreame AURORA smartphones debuted at AWE 2026 with a dual strategy, including…